Search research articles
Contact Us
Filters
Showing results (181-190 of 287) with videos related to
Page
of 29
Sort By:
Journal of Pineal Research
|
March 29, 2001
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia
P Lissoni, R Bucovec, A Bonfanti, et al.
The International Journal of Biological Markers
|
February 17, 2017
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer
P Lissoni, A Bignami, L Frontini, et al.
Anticancer Research
|
November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
P Lissoni, F Brivio, S Barni, et al.
The International Journal of Biological Markers
|
July 14, 2005
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer
P Lissoni, A Bignami, L Frontini, et al.
British Journal of Cancer
|
November 1, 1996
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
P Lissoni, F Paolorossi, G Tancini, et al.
Anticancer Research
|
August 10, 2002
A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines
P Lissoni, R Bucovec, F Malugani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
P Lissoni, S Barni, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
December 20, 2007
Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology
P Lissoni, L Fumagalli, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1993
Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2
P Lissoni, A Ardizzoia, E Tisi, et al.
The European Journal of Medicine
|
November 1, 1992
A clinical study of the pineal hormone melatonin in patients with growth hormone or prolactin secreting pituitary tumours
P Lissoni, E Mainini, F Rovelli, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 287) with videos related to
Sort By:
Page
of 29
Journal of Pineal Research
|
March 29, 2001
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia
P Lissoni, R Bucovec, A Bonfanti, et al.
The International Journal of Biological Markers
|
February 17, 2017
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer
P Lissoni, A Bignami, L Frontini, et al.
Anticancer Research
|
November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
P Lissoni, F Brivio, S Barni, et al.
The International Journal of Biological Markers
|
July 14, 2005
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer
P Lissoni, A Bignami, L Frontini, et al.
British Journal of Cancer
|
November 1, 1996
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
P Lissoni, F Paolorossi, G Tancini, et al.
Anticancer Research
|
August 10, 2002
A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines
P Lissoni, R Bucovec, F Malugani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
P Lissoni, S Barni, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
December 20, 2007
Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology
P Lissoni, L Fumagalli, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1993
Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2
P Lissoni, A Ardizzoia, E Tisi, et al.
The European Journal of Medicine
|
November 1, 1992
A clinical study of the pineal hormone melatonin in patients with growth hormone or prolactin secreting pituitary tumours
P Lissoni, E Mainini, F Rovelli, et al.
Page
of 29